BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38064454)

  • 21. Effects of Liraglutide on Reperfusion Injury in Patients With ST-Segment-Elevation Myocardial Infarction.
    Chen WR; Chen YD; Tian F; Yang N; Cheng LQ; Hu SY; Wang J; Yang JJ; Wang SF; Gu XF
    Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27940956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet inhibition to target reperfusion injury trial: Rationale and study design.
    Bulluck H; Chan MHH; Bryant JA; Chai P; Chawla A; Chua TS; Chung YC; Fei G; Ho HH; Ho AFW; Hoe AJ; Imran SS; Lee CH; Lim SH; Liew BW; Yun PLZ; Hock MOE; Paradies V; Roe MT; Teo L; Wong AS; Wong E; Wong PE; Watson T; Chan MY; Tan JW; Hausenloy DJ
    Clin Cardiol; 2019 Jan; 42(1):5-12. PubMed ID: 30421441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trial design and rationale of TY-51924 as a novel Na+/H+ exchanger inhibitor in patients with ST-elevation acute myocardial infarction undergoing percutaneous coronary intervention.
    Ishihara M; Asakura M; Kimura K; Nakao K; Hamada C; Hirayama A
    J Cardiol; 2014 Jan; 63(1):82-7. PubMed ID: 23860273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized multicenter trial to evaluate early invasive strategy for patients with acute ST-segment elevation myocardial infarction presenting 24-48 hours from symptom onset: Protocol of the RESCUE-MI study.
    Gao W; Zhong X; Ma Y; Huang D; Wang R; Zhao S; Yang S; Qian J; Ge J
    Am Heart J; 2022 Sep; 251():54-60. PubMed ID: 35525262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of the ischemic post-conditioning on the prevention of the cardio-renal damage in patients with acute ST-segment elevation myocardial infarction after primary percutaneous coronary intervention].
    Wang YY; Li T; Liu YW; Liu BJ; Hu XM; Wang Y; Gao WQ; Wu P; Huang L; Li X; Peng WJ; Ning M
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Apr; 45(4):277-282. PubMed ID: 28545277
    [No Abstract]   [Full Text] [Related]  

  • 26. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infarct Size, Shock, and Heart Failure: Does Reperfusion Strategy Matter in Early Presenting Patients With ST-Segment Elevation Myocardial Infarction?
    Shavadia J; Zheng Y; Dianati Maleki N; Huber K; Halvorsen S; Goldstein P; Gershlick AH; Wilcox R; Van de Werf F; Armstrong PW
    J Am Heart Assoc; 2015 Aug; 4(8):e002049. PubMed ID: 26304934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sodium Nitrite-Mediated Cardioprotection in Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: A Cost-Effectiveness Analysis.
    Jones DA; Whittaker P; Rathod KS; Richards AJ; Andiapen M; Antoniou S; Mathur A; Ahluwalia A
    J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):113-119. PubMed ID: 30081658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials.
    Chacko L; P Howard J; Rajkumar C; Nowbar AN; Kane C; Mahdi D; Foley M; Shun-Shin M; Cole G; Sen S; Al-Lamee R; Francis DP; Ahmad Y
    Circ Cardiovasc Qual Outcomes; 2020 Feb; 13(2):e006363. PubMed ID: 32063040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of multivessel coronary artery disease on reperfusion success in patients with ST-elevation myocardial infarction: A substudy of the AIDA STEMI trial.
    de Waha S; Eitel I; Desch S; Fuernau G; Pöss J; Schuler G; Thiele H
    Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):592-600. PubMed ID: 26691729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Nicorandil Administration on Infarct Size in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The CHANGE Trial.
    Qian G; Zhang Y; Dong W; Jiang ZC; Li T; Cheng LQ; Zou YT; Jiang XS; Zhou H; A X; Li P; Chen ML; Su X; Tian JW; Shi B; Li ZZ; Wu YQ; Li YJ; Chen YD
    J Am Heart Assoc; 2022 Sep; 11(18):e026232. PubMed ID: 36073634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCI.
    Adlam D; Zarebinski M; Uren NG; Ptaszynski P; Oldroyd KG; Munir S; Zaman A; Contractor H; Kiss RG; Édes I; Szachniewicz J; Nagy GG; Garcia MJ; Tomcsanyi J; Irving J; Sharp ASP; Musialek P; Lupkovics G; Shirodaria C; Selvanayagam JB; Quinn P; Ng L; Roth M; Insko MA; Haber B; Hill S; Siegel L; Tulloch S; Channon KM
    Int J Cardiol; 2022 Jan; 347():1-7. PubMed ID: 34774885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colchicine for Left Ventricular Infarct Size Reduction in Acute Myocardial Infarction: A Phase II, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Protocol - The COVERT-MI Study.
    Bresson D; Roubille F; Prieur C; Biere L; Ivanes F; Bouleti C; Dubreuil O; Rioufol G; Boutitie F; Sideris G; Elbaz M; Bochaton T; De Bourguignon C; El Jonhy N; Dufay N; Dhelens C; Croisille P; Prunier F; Angoulvant D; Ovize M; Maucort-Boulch D; Mewton N
    Cardiology; 2021; 146(2):151-160. PubMed ID: 33582664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Instantaneous wave-free ratio guided multivessel revascularisation during percutaneous coronary intervention for acute myocardial infarction: study protocol of the randomised controlled iMODERN trial.
    Beijnink CWH; Thim T; van der Heijden DJ; Klem I; Al-Lamee R; Vos JL; Koop Y; Dijkgraaf MGW; Beijk MAM; Kim RJ; Davies J; Raposo L; Baptista SB; Escaned J; Piek JJ; Maeng M; van Royen N; Nijveldt R
    BMJ Open; 2021 Jan; 11(1):e044035. PubMed ID: 33452200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Second Strategic Reperfusion Early After Myocardial Infarction (STREAM-2) study optimizing pharmacoinvasive reperfusion strategy in older ST-elevation myocardial infarction patients.
    Armstrong PW; Bogaerts K; Welsh R; Sinnaeve PR; Goldstein P; Pages A; Danays T; Van de Werf F;
    Am Heart J; 2020 Aug; 226():140-146. PubMed ID: 32553932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evidence-based management of ST-segment elevation myocardial infarction (STEMI). Latest guidelines of the European Society of Cardiology (ESC) 2010].
    Silber S
    Herz; 2010 Dec; 35(8):558-64. PubMed ID: 21107514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial.
    Sabaté M; Brugaletta S; Cequier A; Iñiguez A; Serra A; Hernádez-Antolín R; Mainar V; Valgimigli M; Tespili M; den Heijer P; Bethencourt A; Vázquez N; Backx B; Serruys PW
    JACC Cardiovasc Interv; 2014 Jan; 7(1):64-71. PubMed ID: 24332423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. China Tongxinluo Study for myocardial protection in patients with Acute Myocardial Infarction (CTS-AMI): Rationale and design of a randomized, double-blind, placebo-controlled, multicenter clinical trial.
    Xu Y; Li X; Zhang H; Wu Y; Zhang J; Li J; Dou K; Yan H; You S; Yang Y; Liang Y; Xu L; Gao X; Liu C; Dong Q; Zhang W; Song G; Zhang T; Jiang L; Chen G; Tang R; Jin C; Yang J; Yao C; Xian Y; Peterson ED; Gao R; Yang Y
    Am Heart J; 2020 Sep; 227():47-55. PubMed ID: 32679281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Comparison of the Outcomes between Primary PCI, Fibrinolysis, and No Reperfusion in Patients ≥ 75 Years Old with ST-Segment Elevation Myocardial Infarction: Results from the Chinese Acute Myocardial Infarction (CAMI) Registry.
    Peiyuan H; Jingang Y; Haiyan X; Xiaojin G; Ying X; Yuan W; Wei L; Yang W; Xinran T; Ruohua Y; Chen J; Lei S; Xuan Z; Rui F; Yunqing Y; Qiuting D; Hui S; Xinxin Y; Runlin G; Yuejin Y;
    PLoS One; 2016; 11(11):e0165672. PubMed ID: 27812152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction.
    Chakrabarti AK; Feeney K; Abueg C; Brown DA; Czyz E; Tendera M; Janosi A; Giugliano RP; Kloner RA; Weaver WD; Bode C; Godlewski J; Merkely B; Gibson CM
    Am Heart J; 2013 Apr; 165(4):509-514.e7. PubMed ID: 23537966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.